Here are the results of the recently completed UK trial published in the Emergency Medicine Journal. It found Penthrox significantly reduced pain. Hopefully it leads to sales in the short term.
STOP!: a randomised, double-blind, placebo-controlled study of the efficacy and safety of methoxyflurane for the treatment of acute pain
Conclusion The results of this study suggest that methoxyflurane administered via the Penthrox inhaler is an efficacious, safe, and rapidly acting analgesic.
http://emj.bmj.com/content/early/2014/04/17/emermed-2013-202909.short
Here are the results of the recently completed UK trial...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.025(3.70%) |
Mkt cap ! $78.86M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 72.5¢ | 67.5¢ | $299.8K | 431.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 311 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| MVP (ASX) Chart |